08:05 EST Novavax sees Q1 revenue $300M, consensus $648.29M
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on NVAX:
- Novavax (NASDAQ:NVAX) Gains on Q3 Beat
- Novavax Reports Third Quarter 2023 Financial Results and Operational Highlights
- Options Volatility and Implied Earnings Moves Today, November 09, 2023
- Largest borrow rate increases among liquid names
- Novavax’s Nuvaxovid XBB.1.5 dispersion receives approval in Europe